Anzeige
Mehr »
Login
Samstag, 25.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1W9Z9 | ISIN: SE0003917798 | Ticker-Symbol: 2DG
Tradegate
23.01.25
13:57 Uhr
0,290 Euro
+0,008
+2,70 %
Branche
Halbleiter
Aktienmarkt
Sonstige
1-Jahres-Chart
SIVERS SEMICONDUCTORS AB Chart 1 Jahr
5-Tage-Chart
SIVERS SEMICONDUCTORS AB 5-Tage-Chart
RealtimeGeldBriefZeit
0,2730,29224.01.
0,2780,28624.01.
PR Newswire
161 Leser
Artikel bewerten:
(1)

Sivers Semiconductors AB (publ), publishes Interim Report Q3, January - September 2024

Finanznachrichten News

KISTA, Sweden, Nov. 11, 2024 /PRNewswire/ -- Sivers Semiconductors AB (STO: SIVE), a leading supplier of RF beamformers for Satellite Communications (SATCOM) and Photonics lasers for AI Datacenters, today announced its Q3 2024 results, highlighting its role in addressing two critical secular trends: AI acceleration and mmWave adoption. With a focus on advanced photonics and wireless technologies, Sivers continues to drive innovation in these high-performance, energy-efficient sectors.

Financial Highlights:

  • Q3 2024 revenue totaled SEK 58.7 m, up from SEK 58.3 m in Q3 2023, reflecting a 4% increase at constant currency, demonstrating steady growth despite challenging market conditions.
  • Adjusted EBITDA improved by 12% year-over-year to SEK -11.0 m, indicating continued progress towards profitability, supported by ongoing cost optimization measures and a strategic shift toward higher-margin products.
  • Product revenue increased to 32% of total sales, reflecting Sivers' strategic focus on product sales over NRE (Non-Recurring Engineering) revenue and marking significant progress in transforming into a product delivery business.

Market Focus on AI and mmWave

In Q3, Sivers reinforced its commitment to two secular market trends-AI acceleration and mmWave adoption. The company's Photonics division continues to drive innovation for the AI datacenter segment with high-performance multi-wavelength laser arrays. This was showcased most recently by the joint demonstration with our marquee partner Ayar Labs at the ECOC show in September. Our 16-element laser array solution is a critical enabler for driving the "copper to optical" interconnect paradigm shift. Emphasizing readiness for manufacturing at scale, Sivers is finalizing a merchant foundry partnership to meet the growing demands of AI data centers.

Meanwhile, the Wireless division develops energy efficient RF beamforming ICs with a specific focus on the satellite communications segment. The division recorded 40% sequential growth quarter-over-quarter, and secured a new "blue chip" customer win in the Satcom segment indicating traction beyond early adopters.

"Our technologies play a pivotal role in AI datacenters and satellite communications, which demand the energy-efficient solutions we deliver," said Vickram Vathulya, President and CEO of Sivers Semiconductors. "We continue to deepen and expand our customer engagements, while solving relevant innovation challenges in a timely manner."

Strategic Expansion with CHIPS Act Awards

Sivers secured two U.S. CHIPS Act awards in September, underscoring the strategic importance of our differentiated RF beamforming technology for the large and growing Electronic Warfare (EW) market. These awards highlight our future strategic positioning while acknowledging the dual-use potential in both defense and commercial applications.

Industry Recognition and Outlook

The company's GloTel 2024 Telecom Awards nomination for "Mission Critical Excellence" underscores Sivers' market leadership and innovative role in addressing high-stakes industry challenges with eco-efficient solutions.

Looking ahead, Sivers will continue to explore partnerships and optimize operational scale as it builds a sustainable product revenue base. "With a focus on long-term growth, an evolving product portfolio, and strong ecosystem partnerships, Sivers is well positioned to deliver innovations at scale for the AI and mmWave markets," Vathulya added.

Contact Information
Vickram Vathulya, President and CEO of Sivers Semiconductors
Tel: +46 (0)8 703 68 00
Email: [email protected]

This disclosure contains information that Sivers Semiconductors is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the contact person set out, on 11 November 2024 at 08:00 CET.

About Sivers Semiconductors We are Critical Enablers of a Greener Data Economy with Energy Ef?cient Photonics & Wireless Solutions. Our differentiated high precision laser and RF beamformer technologies help our customers in key markets such as AI datacenters, SATCOM, Defense and Telecom solve essential performance challenges while enabling a much greener footprint. Visit us at: www.sivers-semiconductors.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/sivers-semiconductors/r/sivers-semiconductors-ab--publ--publishes-interim-report-q3--january---september-2024,c4063942

The following files are available for download:

https://mb.cision.com/Main/11695/4063942/3103551.pdf

Sivers Interim report Q324 FINAL_1

SOURCE Sivers Semiconductors

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.